Cargando…
Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications
Since the first polyethylene glycol (PEG)ylated protein was approved by the FDA in 1990, PEGylation has been successfully applied to develop drug delivery systems through experiments, but these experimental results are not always easy to interpret at the atomic level because of the limited resolutio...
Autor principal: | Lee, Hwankyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355693/ https://www.ncbi.nlm.nih.gov/pubmed/32531886 http://dx.doi.org/10.3390/pharmaceutics12060533 |
Ejemplares similares
-
The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia
por: Yatuv, Rivka, et al.
Publicado: (2010) -
Molecular Modeling of Protein Corona Formation and Its Interactions with Nanoparticles and Cell Membranes for Nanomedicine Applications
por: Lee, Hwankyu
Publicado: (2021) -
Maleimide-Decorated PEGylated Mucoadhesive Liposomes
for Ocular Drug Delivery
por: Moiseev, Roman V., et al.
Publicado: (2022) -
PEGylated liposomes enhance the effect of cytotoxic drug: A review
por: Taher, Muhammad, et al.
Publicado: (2023) -
Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)